Medical testing based on FAIMS technology, could allow for the miniaturization of breath testing devices enabling real time, point of care (POC) non-invasive and accurate clinical screening of human breath.
Research shows that human breath contains biomarkers that may be differentially expressed in people who have a specific disease condition compared to healthy individuals. Real time, accurate POC screening of human breath could provide the medical community with a new tool to help screen and possibly diagnose a wide range of human diseases.
It is generally regarded within the global breath research community, that a portable, POC breathalyzer device, that can accurately identify and quantify human breath biomarkers in real-time, could dramatically enhance and improve the current research landscape. This advancement could possibly lead the way to regulatory approved testing.